Latest Breaking News On - புற இரத்தம் தண்டு செல்கள் மாற்று - Page 1 : comparemela.com

Hematopoietic Stem Cell Transplantation (HSCT) Market Size Worth US$ 3.5 Bn By 2027 At A CAGR Of 11.3% iCrowd Newswire 07 May 2021, 03:40 GMT+10 Hematopoietic stem cell transplantation (HSCT) is likely to expand rapidly due to the rising geriatric population coupled with increase in success rates of transplantation and increasing demand for high-quality healthcare services. With the increasing prevalence of hematopoietic disorders across the globe, individuals are opting for better products. Hematopoietic stem cells are also known as hematopoietic progenitor cells (HPCs), present in the bone marrow and blood. Hematopoietic stem cells can quickly produce mature blood cells, such as red blood cells, white blood cells, and platelets. These mature cells are helpful in the treatment of different types of malignant and non-malignant diseases, such as lymphoma, leukemia, hemoglobinopathies, and bone marrow failure. These cells further rebuild or replace a patient s hematopoietic system,

United statesAnishi sharmaCellgenix gmbKiadis pharmaRegen biopharma incTalaris therapeutics incLonza groupStempeutics research pvt ltdTakeda pharmaceutical companyTaiga biotechnologies incResearch newswireSee campaignTherapeutics incMarker therapeutics incPluristem therapeutics incGlobal hematopoietic stem cell transplantation